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ABSTRACT
Background and objective Clinical guidelines dis-
courage antibiotic prescribing for many acute res-
piratory infections (ARIs), especially for non-
antibiotic appropriate diagnoses. Electronic health
record (EHR)-based clinical decision support has
the potential to improve antibiotic prescribing for
ARIs.
Methods We randomly assigned 27 primary care
clinics to receive an EHR-integrated, documentation-
based clinical decision support system for the care
of patients with ARIs – the ARI Smart Form – or to
oﬀer usual care. The primary outcome was the
antibiotic prescribing rate for ARIs in an intent-
to-intervene analysis based on administrative diag-
noses.
Results During the intervention period, patients
made 21 961ARI visits to study clinics. Intervention
clinicians used the ARI Smart Form in 6% of 11 954
ARI visits. The antibiotic prescribing rate in the
intervention clinics was 39% versus 43% in the
control clinics (odds ratio (OR), 0.8; 95% conﬁ-
dence interval (CI), 0.6–1.2, adjusted for clustering
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Introduction
Acute respiratory infections (ARIs) – including non-
speciﬁc upper respiratory infections, otitis media,
sinusitis, pharyngitis, acute bronchitis, pneumonia
and inﬂuenza – are the most common symptomatic
reason for seeking ambulatory care in the USA, ac-
counting for approximately 7% of visits.1 ARIs are
also the number one reason for antibiotic prescribing
in the USA, accounting for about 50% of antibiotic
prescriptions to adults.2Guidelines and reviews fromthe
USA and internationally generally discourage anti-
biotic prescribing for ARIs,3–8 but much antibiotic
prescribing for ARIs is inappropriate due to prescrib-
ing antibiotics for viral conditions or prescribing
unnecessarily broad-spectrum antibiotics.9–11 Inap-
propriate antibiotic prescribing increases medical costs,
increases the prevalence of antibiotic resistant bac-
teria, and needlessly exposes patients to adverse drug
events.12,13
Electronic health records (EHRs) with clinical deci-
sion support have shown potential for improving the
quality of medical care, mainly through the use of
prescribing alerts and preventive care reminders.14
Improving care for ARIs through decision support
may be more challenging than for chronic problems,
because the quality problem is an error of commis-
sion, decision support must be delivered during
patient visits and ARI visits are typically brief.15,16
We designed an EHR-integrated, documentation-
based clinical decision support system for the care of
patients with ARIs, the ARI Smart Form. We designed
the ARI Smart Form with two principal objectives: to
assist clinicians in reducing inappropriate antibiotic
prescribing and to improve workﬂow for clinicians.
We have previously reported results of usability testing
and pilot testing, which showed the potential of the
ARI Smart Form to be incorporated into clinical
practice and reduce inappropriate antibiotic prescrib-
ing.17,18 To evaluate the ARI Smart Form in actual
practice, we conducted a cluster randomised controlled
trial in primary care clinics.
Methods
Setting and EHR
Partners HealthCare System is an integrated regional
healthcare delivery system in eastern Massachusetts.
The main EHR used in Partners HealthCare ambulat-
ory clinics is the longitudinal medical record, or LMR.
The LMR is an internally developed, full featured
EHR, approved by the Certiﬁcation Commission for
Healthcare Information Technology and including;
primary care and subspecialty notes; problem lists;
medication lists; coded allergies; and laboratory test
and radiographic study results.19
The ARI Smart Form
The ARI Smart Form has been described previously.17,18
Brieﬂy, the ARI Smart Form is an LMRmodule that is
launched from the notes page of the EHR and is
designed to be used while interviewing and evaluating
patients. The ARI Smart Form includes six com-
ponents: entry of clinical information; patient data
display; diagnosis selection; presentation of treatment
options with integrated decision support; printing of
patient handouts and access to supporting medical
literature. The ARI Smart Form imports patients’
problem lists, allergies, medications and vital signs
by clinic). For antibiotic appropriate ARI diagnoses,
the antibiotic prescribing rate was 54% in the
intervention clinics and 59% in the control clinics
(OR, 0.8; 95% CI, 0.5–1.3). For non-antibiotic
appropriate diagnoses, the antibiotic prescribing
rate was 32% in the intervention clinics and 34%
in the control clinics (OR, 0.9; 95% CI, 0.6–1.4).
When the ARI Smart Form was used, based on
diagnoses entered on the form, the antibiotic pre-
scribing rate was 49% overall, 88% for antibiotic
appropriate diagnoses and 27% for non-antibiotic
appropriate diagnoses. In an as-used analysis, the
ARI Smart Form was associated with a lower anti-
biotic prescribing rate for acute bronchitis (OR, 0.5;
95% CI, 0.3–0.8).
Conclusions The ARI Smart Form neither reduced
overall antibiotic prescribing nor signiﬁcantly
improved the appropriateness of antibiotic pre-
scribing for ARIs, but it was not widely used.
When used, the ARI Smart Form may improve
diagnostic accuracy compared to administrative
diagnoses and may reduce antibiotic prescribing
for certain diagnoses.
Keywords: antibacterial agents, computerised med-
ical record systems, clinical decision support sys-
tems, respiratory tract infections
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into the visit note; speeds workﬂow using drop-down
lists, radio buttons and check boxes; and provides
‘one-click’ ordering of medicines, patient handouts,
and excuse-from-work letters. The ARI Smart Form
automatically generates a narrative visit note that would
usually meet Evaluation and Management criteria for
a Level 4 visit (moderate severity on a one to ﬁve scale).
The ARI Smart Form provides decision support in
several ways. First, clinicians’ selection of a particular
ARI diagnosis results in the generation of a diagnosis
appropriate order set. Antibiotic prescribing and anti-
biotic choices are based on the recommendations of
the Centers for Disease Control and Prevention (CDC)
and the American College of Physicians (ACP).8 At
a basic level, the ARI Smart Form decision support
strives to make the antibiotic treatment match the
diagnosis (e.g. not prescribing antibiotics for patients
with acute bronchitis). Second, the ARI Smart Form
provides diagnostic decision support by calculating
the probability of streptococcal pharyngitis based on
signs and symptoms entered by the clinician, and also
how rapid streptococcal testing will change the prob-
ability of streptococcal pharyngitis.20 Third, the ARI
Smart Form has medication prescribing alerts regard-
ing potential medication interactions or patient aller-
gies. Fourth, the ARI Smart Form supports clinicians
by providing easy access to diagnosis appropriate
patient handouts. The handouts contain information
about the diagnosis and why antibiotics may or may
not be indicated. Mainly through the use of diagnosis
appropriate order sets, we strove to make it easy for
clinicians to follow ARI antibiotic prescribing guide-
lines.21
Clinic matching and randomisation
We randomly assigned 27 primary care clinics asso-
ciated with Partners HealthCare that use the LMR to
participate in the study. With the exception of a single
clinic that was randomly assigned on its own, clinics
were matched on the basis of size. Matched pairs were
randomised simultaneously, with one practice from
each pair assigned to receive the intervention and the
other assigned to oﬀer usual care.
Intervention and implementation
The intervention period was from 3 November 2005
to 31May 2006. The lead co-investigator (JAL) visited
each of the 13 intervention clinics once for up to an
hour at the beginning of the intervention period to
introduce and describe the ARI Smart Form to clin-
icians. Clinicians had access to an online RoboDemoTM
introduction to the ARI Smart Form functionality.
Throughout the intervention period, monthly emails
were sent to intervention clinics reminding clinicians
about the ARI Smart Form and providing summary
ARI Smart Form usage counts at each clinic, compared
to other clinics. The Human Research Committee of
Partners HealthCare approved the study protocol.
Outcomes
The primary outcome was the antibiotic prescribing
rate for ARI visits, based on electronic prescribing
using the EHR, using an intent-to-intervene analysis.
We had previously found that EHR based antibiotic
prescribing had a sensitivity of 43%, but was increas-
ing rapidly over time, from 22% in 2000 to 58% in
2003.22 During the intervention period, it was the
policy of study clinics that all prescriptions be written
using the EHR. We deﬁned antibiotic use as the pre-
scription of an orally administered antibiotic agent
within three days of an ARI visit. Secondary outcomes
included antibiotic prescribing for antibiotic appro-
priate diagnoses, non-antibiotic appropriate diagnoses
and individual ARI diagnoses; the 30-day revisit rate;
and the 30-day revisit rate attributable to ARIs (i.e. a
second visit within 30 days of the index ARI visit with
another ARI diagnosis). We also performed as-used
analyses, comparing antibiotic prescribing rates in
clinic visits in which the ARI Smart Form was used
to visits in the control clinics.
Data collection and analysis
We examined baseline characteristics of the control
and intervention clinics and clinicians. We identiﬁed
ARI visits using administrative data coded using the
International Classiﬁcation of Diseases, Ninth Edition,
Clinical Modiﬁcation (ICD-9-CM) codes. ARI visits
were those with any ICD-9-CM code for non-speciﬁc
upper respiratory infections (ICD-9-CM 460, 464 and
465), otitis media (ICD-9-CM 381 and 382), sinusitis
(ICD-9-CM 461 and 473), pharyngitis (streptococcal
and non-streptococcal; ICD-9-CM 034.0, 462 and 463),
acute bronchitis (ICD-9-CM 466 and 490), inﬂuenza
(ICD-9-CM 487) and pneumonia (ICD-9-CM 481–
486). These administrative data have a sensitivity of
98%, speciﬁcity of 96% and positive predictive value of
96% compared with medical record review.22 We
considered otitis media, sinusitis, streptococcal phar-
yngitis, and pneumonia to be antibiotic appropriate
diagnoses. We considered non-speciﬁc upper respir-
atory tract infections, non-streptococcal pharyngitis,
acute bronchitis and inﬂuenza to be non-antibiotic
appropriate diagnoses.
During the intervention, we measured the number
of visits, the number of ARI visits and, for clinicians in
the intervention practices, whether clinicians ever
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used the ARI Smart Form. Using registration data, we
examined patient age, gender, race/ethnicity, primary
language, primary insurance and mean income by zip
code. For intervention visits at which the ARI Smart
Form was used, we recorded the duration of use (i.e.
the amount of time between opening and submitting
the ARI Smart Form).
Statistical analysis and power
calculation
We used standard descriptive statistics to compare
clinicians and patients. To account for the level of
randomisation, we adjusted all statistical analyses –
the chi-squared test for categorical variables and
Student’s t-test for continuous variables – for cluster-
ing by practice using PROCGENMOD in SAS version
9.1 (SAS Institute Inc., Cary, NC). For visits in which
the ARI Smart Form was used, we used chance-
corrected k with 95% conﬁdence intervals to assess
the degree of agreement between the ICD-9 diagnosis
and the ARI Smart Form listed diagnosis.23 We con-
sidered two-sided P values < 0.05 signiﬁcant. As-
suming a baseline antibiotic prescribing rate for ARIs
of 35%,  of 0.05 and an intra-class correlation
coeﬃcient of 0.10, 1798 visits in each group were
required to have 80% power to detect a 7% absolute
reduction in the antibiotic prescribing rate.22
Results
Clinic, clinician and patient
characteristics
Prior to the intervention, there were no diﬀerences
between the intervention and control clinics in dur-
ation of EHR use, overall antibiotic prescribing rates
or ARI antibiotic prescribing rates (data not shown).
During the seven-month intervention period, there
were 214 900 visits by 111 820 patients to 443 clin-
icians in the 27 control and intervention practices
(Figure 1). There were no signiﬁcant diﬀerences in the
clinicians or the patients between the control and
intervention clinics (Table 1 and Table 2). There was
no diﬀerence in the ARI visit rate between control
clinics (10% (10 007/98 894)) and intervention clinics
(10% (11 954/116 006); P = 0.89).
ARI Smart Form use
In intervention clinics, 33% (86/262) of clinicians
used the ARI Smart Form at least once (Table 1).
Based on ICD-9 codes, the ARI Smart Form was used
in 6% (742/11 954) of ARI visits (Table 3). For
intervention ARI visits at which the ARI Smart Form
was used, the duration of form use was 8.1 (standard
deviation, 5.8) minutes.
Antibiotic prescribing
In the intent-to-intervene analysis, clinicians pre-
scribed antibiotics to 43% of patients with ARI diag-
noses in control clinics and to 39% of patients with
ARI diagnoses in intervention clinics (OR, 0.8; 95%
CI, 0.6–1.2;P=0.30; Table 3). Therewas no signiﬁcant
diﬀerence in antibiotic prescribing for antibiotic ap-
propriate ARIs (OR, 0.8; 95% CI, 0.5–1.3) or for non-
antibiotic appropriate ARIs (OR, 0.9; 95% CI, 0.6–
1.4). There was also no signiﬁcant diﬀerence in anti-
biotic prescribing between control and intervention
clinics for non-ARI visits (5% in control clinics versus
6% in intervention clinics; OR, 1.1; 95% CI, 0.9–1.3)
or for all visits (9% in both control and intervention
clinics; OR, 1.0; 95% CI, 0.8–1.2).
In the as-used analysis, for visits in which the ARI
Smart Form was used (n = 990), there was good
Figure 1 Randomisation
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agreement between the ICD-9 diagnosis and the ARI
Smart Form listed diagnosis (k, 0.54; 95% CI, 0.50–
0.58). In the as-used analysis with diagnoses derived
from the ARI Smart Form, antibiotic prescribing rates
were 88% for antibiotic appropriate diagnoses
(compared with 59% in control visits; OR, 5.0; 95%
CI, 2.9–8.6), 27% for non-antibiotic appropriate di-
agnoses (compared with 34%; OR, 0.7; 95% CI, 0.5–
1.0) and 49% for all ARI diagnoses (compared with
43%; OR, 1.3; 95% CI, 0.8–2.0). In the as-used
analysis, the antibiotic prescribing rate was lower for
acute bronchitis (45% vs 61%, OR, 0.5 compared to
control clinics; 95% CI, 0.3–0.8).
Revisit rates
The 30-day revisit rate to study clinics for control ARI
visits was 26% (2566/10 007) and for intervention
visits was 23% (2765/11 954; P = 0.32). The 30-day
revisit rate to study clinics attributable to ARIs was 9%
(913/10 007) in control clinics and 8% (969/11 954) in
intervention clinics (P = 0.29).
Discussion
We evaluated the ARI Smart Form, a documentation-
based clinical decision support system, in a cluster
randomised controlled trial. The point estimates for
antibiotic prescribing for all ARI diagnoses, antibiotic
appropriate ARI diagnoses and non-antibiotic appro-
priate ARI diagnoses were less than 1.0. As used, the
ARI Smart Form was associated with a marginal
reduction in antibiotic prescribing for non-antibiotic
appropriate diagnoses and a reduction in antibiotic
prescribing for acute bronchitis, one of two diagnoses
that account for the majority of ARI antibiotic pre-
scribing.2 However, these ﬁndings were either not
statistically signiﬁcant or were subgroup analyses that
may not generalise to the entire population making
Table 1 Clinician characteristics
Characteristic Control
(n = 181)
Intervention
(n = 262)
P valuea
Age, years (SD)b 39 (11) 39 (12) 0.74
Type of clinician, n (%) 0.11
Staﬀ physician 98 (54) 115 (44)
Fellow 4 (2) 14 (5)
Resident 66 (36) 105 (40)
NP or PAc 8 (4) 23 (9)
Other 5 (3) 5 (2)
Female, n (%) 115 (64) 143 (55) 0.12
Experienced with EHR, %d 78 71 0.23
Visits during intervention period, mean 546 443 0.45
ARI visits, meane 55 46 0.52
At least one ARI visit, n (%) 172 (95) 248 (95) 0.84
Clinicians who submitted at least one ARI Smart
Form, n (%)
NAf 86 (33) NA
aP values adjusted for clustering by clinic, except for ‘experience with EHR’
b SD, standard deviation
cNP, nurse practitioner; PA, physician assistant
d EHR, electronic health record. In the control group, 62 of 79 respondents said they were ‘somewhat experienced’ or ‘very
experienced’ at using the electronic health record in a pre-intervention survey. In the intervention group, 80 of 113 respondents
said they were ‘somewhat experienced’ or ‘very experienced’ at using the electronic health record.
e ARI, acute respiratory infection
f NA, not applicable
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ARI visits. In the primary intent-to-intervene analysis,
theARI Smart Formwas not associatedwith improved
antibiotic prescribing for ARIs overall. The main reason
for this ﬁnding was the poor uptake of the ARI Smart
Form.
We designed theARI Smart Form to have self-evident
value to clinicians. It was our hope that it would
eﬀectively facilitate documentation, improve workﬂow
and provide integrated decision support.We designed
the ARI Smart Form to include three of the four clinical
decision support characteristics associated with im-
proved clinical practice: provision of recommendations
rather than just assessments; provision of decision
support at the time and location of decision making;
and computer-based decision support.24 Why then
was the ARI Smart Form used in so few visits?
First, we were missing the fourth characteristic of
successful clinical decision support applications:
the automatic provision of decision support as part
of clinicians’ workﬂow.24 Clinicians had to actively
invoke the ARI Smart Form from the notes page. Such
voluntarily invoked applications may go unused, in
part because clinicians do not think they need decision
support.25 Second, the ARI Smart Formmay not have
felt suﬃciently integrated with the rest of the EHR.
The ARI Smart Form, when invoked, appeared in a
separate window, unlike other methods of documen-
tation within the EHR. To be most eﬀective, clinical
decision supportmust ﬁt as seamlessly as possible into
existing workﬂow and allow clinicians to manage
unanticipated interruptions.21,26
Third, the ARI Smart Form introduced new con-
cepts in documentation for our EHR: drop-down lists,
check boxes, radio buttons and automatic generation
of a narrative note. Clinicians may have been turned
oﬀ by what they felt was new complexity that could
lead to a loss of overview, fragmentation of thinking
and an overly detailed and unhelpful resulting note,26
especially for a medical problem generally perceived
to be straightforward. Fourth, the ARI Smart Form
Table 2 Patient characteristics
Characteristic Control
(n = 49 315)
Intervention
(n = 62 505)
P valuea
Clinic visits per patient in the last three years,
mean (SD)
6.0 (6.4) 5.0 (5.4) 0.22
Age, mean years (SD)b 48 (17) 49 (17) 0.97
Female, n (%) 33 768 (69) 38 281 (61) 0.22
Race and ethnicity, n (%) 0.66
White 28 469 (58) 30 265 (48)
Latino 4327 (9) 11 331 (18)
Black 3660 (7) 5722 (9)
Other or unknown 12 859 (26) 15 187 (24)
Language, n (%) 0.55
English 42 092 (85) 48 361 (77)
Spanish 3411 (7) 9175 (15)
Other 3812 (8) 4969 (8)
Primary insurance, n (%) 0.95
HMOc 14 697 (30) 16 447 (26)
Private 17 511 (36) 20 025 (32)
Medicare 7975 (16) 10 543 (17)
Medicaid 3877 (8) 6128 (10)
Free care 1995 (4) 3996 (6)
Self-pay 1400 (4) 2624 (4)
Other 1860 (4) 2742 (4)
Income by zip code, mean $ (SD) 63 113 (37 063) 62 182 (40 239) 0.88
a P values adjusted for clustering by clinic
b SD, standard deviation
c HMO, health maintenance organisation
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introduced a lack of ﬂexibility. Clinicians needed to
make a determination at the beginning of the visit or
the beginning of documentation whether or not they
were going to use the ARI Smart Form. Clinicians may
have feared being ‘locked-in’ to using the ARI Smart
Form when they were unsure whether the visit would
include other problems.26 Finally, some clinicians –
our prior work would suggest about 25% – may not
use the EHR at all during patient visits.27
Even as-used, the ARI Smart Form was only asso-
ciated with, at best, modest improvements in diagnostic
accuracy and antibiotic prescribing. ARI Smart Form
use was also associated with increased antibiotic pre-
scribing for antibiotic appropriate diagnoses. Whether
these results are due to more appropriate prescribing,
better matching of diagnosis to treatment, or both is
not clear. Why was the ARI Smart Form, as-used, not
eﬀective in reducing the antibiotic prescribing rate?
First, there is the usual list of reasons that clinicians
cite for prescribing antibiotics for predominantly viral
ARIs – diagnostic uncertainty, lack of time, patient
desire and fear of complications, among others – and a
lack of compelling reasons for clinicians to change
practice patterns.13,28,29 Second, contributing to diag-
nostic and therapeutic uncertainty, there are compet-
ing and conﬂicting guidelines for some ARIs.30 Third,
providers may be concerned that the recommendations
will not be applicable to their patients or will not be
tolerated (i.e. because of comorbidities or contraindi-
cations).31 Fourth, clinicians may have preferentially
used the ARI Smart Form when they were going to
prescribe antibiotics. Finally, there may be particular
challenges to providing decision support for acute
problems and errors of commission. Most decision
support applications for ambulatory care have addressed
errors of omission for chronic problems.24,32 Itmay be
Table 3 Antibiotic prescribing by ARI diagnosisa
Control Intervention
Intent-to-intervene Smart Form as used
ICD-9 codesb Smart Form diagnosis
n Antibiotic
n (%)
n Antibiotic
n (%)
n Antibiotic
n (%)
n Antibiotic
n (%)
Antibiotic appropriate diagnoses
Pneumonia 604 195 (32) 765 280 (37) 32 28 (88) 38 33 (87)
Streptococcal
pharyngitis
123 75 (61) 65 47 (72) 9 9 (100) 75 69 (92)
Sinusitis 2457 1587 (65) 2294 1310 (57) 164 143 (87) 191 167 (87)
Otitis media 587 351 (60) 612 363 (59) 32 25 (78) 41 33 (81)
Sub-total 3771 2208 (59) 3736 2000 (54) 237 205 (87) 345 302 (88)
Non-antibiotic appropriate diagnoses
Non-streptococcal
pharyngitis
2176 726 (33) 2771 857 (31) 165 86 (52) 56 11 (20)
Inﬂuenza 54 6 (11) 204 21 (10) 10 0 (0) 81 13 (16)
Acute bronchitis 1433 875 (61) 1649 833 (51) 100 53 (53) 221 99 (45)
Non-speciﬁc URI 2573 501 (19) 3594 890 (25) 230 35 (15) 236 36 (15)
Sub-total 6236 2108 (34) 8218 2601 (32) 505 174 (35) 594 159 (27)
ARI visitsc 10 007 4316 (43) 11 954 4601 (39) 742 379 (51) 939 461 (49)
Non-ARI visits 88 887 4727 (5) 104 052 5957 (6) 248d 97 (39) 51e 15 (29)
Total visits 98 894 116 006 990 990
aARI, acute respiratory infection
b ICD-9 – International Classiﬁcation of Diseases, 9th Edition, Clinical Modiﬁcation
c The primary outcome was the intent-to-intervene analysed diﬀerence in antibiotic prescribing between control and intervention
practices for acute respiratory infection visits in aggregate, adjusted for clustering by clinic (odds ratio, 0.8; 95% conﬁdence interval,
0.6–1.2; P = 0.30)
d The most common diagnoses for these 248 visits were cough (36%), no diagnosis given (29%), unspeciﬁed viral infection (10%),
allergic rhinitis (4%) and asthma (2%)
e The most common diagnoses for these 51 visits were other diagnoses (31%), allergies (25%), cough (19%) and asthma (12%)
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inherently more diﬃcult to provide decision support
that strives to have clinicians not do something in the
context of a single visit than to encourage clinicians to
take an action over time for a chronic problem.21
There have been many other examples of clinical
decision support implementation failures reported in
the medical literature. These failures have included
order entry decision support for hypertension, con-
gestive heart failure, coronary artery disease, asthma
and chronic obstructive pulmonary disease;31,33–36 an
EHR based clinical decision support system for the
management of asthma and angina in primary care;37,38
a computer clinical decision support system to reduce
cardiovascular risk for patients with hypertension;39
and reminders for the care of chronic conditions.40,41
For all these failures, Samore and colleagues had
notable success with introducing paper and personal
digital assistant based clinical decision support to
rural communities to increase the appropriateness of
antibiotic prescribing for ARIs.42 Communities that
received clinical decision support had a reduction in
antibiotic prescribing and clinicians in those com-
munities reduced antibiotic prescribing for non-anti-
biotic appropriate diagnoses. The implementation by
Samore and colleagues was extremely intensive: they
reached 71% of clinicians in intervention communi-
ties; contacted pharmacies, mayors, health departments
and school superintendents; and distributed thou-
sands of posters, brochures and household mailings.
This intensity of implementationwas probably critical
to its success.
In the future, other than the design issues addressed
above, what steps could ensure that applications similar
to the ARI Smart Form are used? First, the introduc-
tion and training should be more intensive. For this
trial, the introduction of the ARI Smart Form was
limited and weak. The lead investigator introduced
the application with a single site visit at which only
some of a practice’s clinicians were present. This visit
was followed with monthly emails to all intervention
providers, but the application was not formally sup-
ported. A single visit and seven emails is probably not
enough to encourage users to try a new application
intended for use during patient visits. Broad program-
matic support with a phased roll-out, with more
intensive introduction and training at each clinic, may
have been more successful.43 Second, with such a
limited and weak introduction strategy, the seven-
month intervention period may not have allowed
enough time for knowledge of the application to have
diﬀused through the intervention clinics. Since the
endof the study,withnopromotion, theARISmart Form
has been available throughout the Partners HealthCare
system. From June 2006 to February 2009, over 450
clinicians used the ARI Smart Form 13435 times and a
newer paediatric version of the ARI Smart Form was
used 2722 times by about 70paediatricians. Clearlymany
clinicians – admittedly a minority – are ﬁnding some
value in using the ARI Smart Form. Finally, our experi-
ence highlights the importance of ongoing cycles of
usability testing and application reﬁnement prior to
widespread roll-out. Moving forward, we should go
back to focus groups of users and non-users to ﬁnd out
more about what they did not like about the ARI
Smart Form and make design changes. Qualitative
research is critical to understanding how and why the
ARI Smart Form went unused and if future modiﬁ-
cations are worthwhile.26,38
Our study has several limitations that should be
considered. First, our identiﬁcation of ARI visits was
dependent on claims diagnoses. We had previously
found that claims diagnoses for ARIs were accurate,22
but there was probably some degree of diagnostic
misclassiﬁcation. This is apparent in examining speciﬁc
ARI diagnoses in the as-used intervention group when
the diagnosis was determined using ICD-9-CM codes
or the ARI Smart Form diagnosis. This also reveals
another potential beneﬁt of applications like the ARI
Smart Form – improvement in documentation and
coding. Second, we identiﬁed antibiotic prescribing
only using the EHR. Prescriptions that were hand-
written or phoned-in without EHR entry or that
occurred outside the context of a visit could bemissed,
but we would expect this to be increasingly rare in the
Partners HealthCare system.22 Finally, the trial was
conducted in academically aﬃliated primary care clinics
using a locally developed system, possibly limiting the
extent to which it can be generalised.
Conclusion
In conclusion, introduction of a documentation-based
clinical decision support system for the care of patients
with ARIs did not result in signiﬁcant changes in
antibiotic prescribing, primarily because the application
went largely unused. Even as-used, the ARI Smart Form
was not clearly associated with improved antibiotic pre-
scribing. For similar applications, developers should
ensure their applications are well integrated into
workﬂow and signiﬁcant resources are dedicated to
implementation. To decrease inappropriate antibiotic
prescribing for ARIs, many other strategies beyond
clinician directed computerised clinical decision sup-
port can be employed: physician education, physician
audit and feedback (including counter-detailing and
use of opinion leaders), patient education, multi-
dimensional interventions, delayed antimicrobial pre-
scriptions and ﬁnancial or regulatory incentives.44–46
However, health information technology is likely to be
part of the solution in improving quality. As ARIs are
the primary reason for antibiotic prescribing, much of
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it inappropriate, there remains a need for scalable and
eﬀective technology interventions that decrease inap-
propriate antibiotic prescribing.
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